246 related articles for article (PubMed ID: 15578211)
1. Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?
Smeenk HG; Tran TC; Erdmann J; van Eijck CH; Jeekel J
Langenbecks Arch Surg; 2005 Apr; 390(2):94-103. PubMed ID: 15578211
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pancreatic cancer: challenge of the facts.
Beger HG; Rau B; Gansauge F; Poch B; Link KH
World J Surg; 2003 Oct; 27(10):1075-84. PubMed ID: 12925907
[TBL] [Abstract][Full Text] [Related]
3. Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.
Picozzi VJ; Oh SY; Edwards A; Mandelson MT; Dorer R; Rocha FG; Alseidi A; Biehl T; Traverso LW; Helton WS; Kozarek RA
Ann Surg Oncol; 2017 Jun; 24(6):1722-1730. PubMed ID: 28054192
[TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.
Yeo CJ; Cameron JL; Lillemoe KD; Sitzmann JV; Hruban RH; Goodman SN; Dooley WC; Coleman J; Pitt HA
Ann Surg; 1995 Jun; 221(6):721-31; discussion 731-3. PubMed ID: 7794076
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas.
Hoffman JP; Weese JL; Solin LJ; Engstrom P; Agarwal P; Barber LW; Guttmann MC; Litwin S; Salazar H; Eisenberg BL
Am J Surg; 1995 Jan; 169(1):71-7; discussion 77-8. PubMed ID: 7818001
[TBL] [Abstract][Full Text] [Related]
6. Resection and radiochemotherapy of pancreatic cancer--the future?
Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
[TBL] [Abstract][Full Text] [Related]
7. Strategies to improve local control of resected pancreas adenocarcinoma.
Sugarbaker PH
Surg Oncol; 2017 Mar; 26(1):63-70. PubMed ID: 28317586
[TBL] [Abstract][Full Text] [Related]
8. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
10. Rationale of the so-called extended resection for pancreatic invasive ductal carcinoma.
Imamura M; Hosotani R; Kogire M
Digestion; 1999; 60 Suppl 1():126-9. PubMed ID: 10026446
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
Kuhlmann KF; de Castro SM; Wesseling JG; ten Kate FJ; Offerhaus GJ; Busch OR; van Gulik TM; Obertop H; Gouma DJ
Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment of pancreatic cancer: curative resections].
Baulieux J; Delpero JR
Ann Chir; 2000 Sep; 125(7):609-17. PubMed ID: 11051689
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
14. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
Conlon KC; Klimstra DS; Brennan MF
Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
18. Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: analysis of early outcome data.
Townend P; de Reuver PR; Chua TC; Mittal A; Clark SJ; Pavlakis N; Gill AJ; Samra JS
ANZ J Surg; 2018 Mar; 88(3):E167-E172. PubMed ID: 28318082
[TBL] [Abstract][Full Text] [Related]
19. Status of 5-Year Survivors of the Whipple Procedure for Pancreatic Adenocarcinoma.
Mehtsun WT; Hashimoto DA; Ferrone CR
Adv Surg; 2019 Sep; 53():253-269. PubMed ID: 31327451
[No Abstract] [Full Text] [Related]
20. Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.
Osipov A; Nissen N; Rutgers J; Dhall D; Naziri J; Chopra S; Li Q; Hendifar AE; Tuli R
Ann Surg Oncol; 2017 Nov; 24(12):3674-3682. PubMed ID: 28871564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
